• Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Ask AI
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)
    • Services
      • Equity Reports (Analyst-Ready)
      • Visibility Upgrades (Quartely + As needed)
      • Investor Mapping
    • Press
    • Ask AI
    • Contact
    • English
      • Deutsch (German)
      • 日本語 (Japanese)
  • info@vasro.de
  • +49 (0)69 90 28 39 81
  • Call us Mon - Fri: 8:30 AM - 6:00 PM
VASRO GmbH
VASRO GmbH
  • Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Ask AI
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)

Press

VASRO GmbH > Press
VASRO GmbH

GAAP vs Non-GAAP: Why Companies Use Adjusted Metrics

  • October 27, 2025
  • Unkategorisiert
GAAP vs Non-GAAP metrics help companies highlight core performance by adjusting for one-time items, aiding investors in clearer financial analysis.
Continue Reading
VASRO GmbH

Pharma Innovation Spotlight: Equity Report Analysis of mRNA and Gene Editing

  • October 24, 2025
  • Equity Analysis reports
Pharma Innovation Spotlight reveals equity trends, investment insights, and market leaders driving mRNA and gene editing breakthroughs in biotech.
Continue Reading
VASRO GmbH

How We Source, Clean and Verify Financial Data

  • October 23, 2025
  • Unkategorisiert
Source financial data from trusted systems, clean for accuracy, and verify integrity with automation and audits to ensure reliable financial reporting.
Continue Reading
VASRO GmbH

Why Asia-Pacific Issuers Should Embrace Independent Equity Research for IR

  • October 22, 2025
  • Unkategorisiert
Asia-Pacific Issuers gain trust, global investor reach, and fair valuation by adopting independent equity research for stronger investor relations.
Continue Reading
VASRO GmbH

ESG Data in 2025: What’s Mandatory vs Voluntary in Major Markets

  • October 21, 2025
  • Unkategorisiert
ESG Data in 2025: See which disclosures are mandatory or voluntary in the EU, US, UK, and Australia, and how new rules affect your compliance strategy.
Continue Reading
VASRO GmbH

EUV/High-NA Orders & Backlog in ASML Q3 2025

  • October 20, 2025
  • Tech
ASML’s Q3 2025 EUV/High-NA orders and backlog highlight strong demand, robust growth prospects, and the company’s continued leadership in advanced lithography.
Continue Reading
VASRO GmbH

TSMC Ergebnisse für das 3. Quartal 2025 und KI-Kapazität

  • October 17, 2025
  • Tech
TSMC’s Q3 2025 results show record profits and major AI capacity expansion, positioning the company as a leader in advanced AI chip manufacturing.
Continue Reading
Answering the Most Common Reader Questions on Earnings and Economic Indicators

Answering the Most Common Reader Questions on Earnings and Economic Indicators

  • October 16, 2025
  • Unkategorisiert
Reader Questions answered: How do earnings reports and economic indicators impact your investments? Get clear, actionable insights for smarter decisions.
Continue Reading
VASRO GmbH

Big Banks Recap and the Outlook for Small Cap Profits

  • October 15, 2025
  • Unkategorisiert
Big Banks Recap: See how major bank earnings and Fed policy shifts shape small cap profit outlook, investor sentiment, and market opportunities for 2025.
Continue Reading
VASRO GmbH

Why US Public Companies Should Prioritize Independent Equity Research

  • October 14, 2025
  • Unkategorisiert
US Public Companies gain investor trust and long-term value by prioritizing independent equity research for unbiased insights and transparent analysis.
Continue Reading

Posts pagination

Previous 1 … 9 10 11 … 37 Next

Search

Categories

  • Energy
  • Equity Analysis reports
  • Equity Research Coverage
  • Market Intelligence
  • Pharma & Biotech
  • Tech
  • Unkategorisiert

Recent Posts

Sirnaomics Ltd.: The RNAimmune Money Is In, and the FDA Has Answered in Writing on STP705 October 12, 2026
Ainos, Inc.: A Partner Pays for VELDONA, and Ainos Keeps the Platform September 29, 2026
Ainos Inc: A Front-End Customer Starts Ordering, and the Dataset Passes a Billion September 16, 2026
Ainos, Inc.: Three Patents Approved in Japan, and a Dataset Gathering Pace September 11, 2026
Baladna: The Capital Is Raised, Algeria Is Building – VASRO Reiterates BUY at QAR 2.33 September 7, 2026
VASRO GmbH
VASRO GmbH specializes in equity analysis, market intelligence, and investment strategy for the pharmaceutical, biotechnology, and IT sectors. We deliver tailored insights to drive informed investment decisions and achieve exceptional results.

Discover More

Contact Info

  • Am Hauptbahnhof 16, 60329 Frankfurt am Main, Germany
  • +49 (0)69 90 28 39 81
  • info@vasro.de
  • 8:30 AM - 6:00 PM

Navigation

  • Imprint
  • Privacy Policy
  • Change privacy settings
  • Application
  • About
  • FAQ

©copyright 2025 VASRO GmbH.